Medication safety review hkeh qa forum 2012
Sponsored Links
This presentation is the property of its rightful owner.
1 / 49

Medication Safety Review HKEH QA Forum 2012 PowerPoint PPT Presentation


  • 146 Views
  • Uploaded on
  • Presentation posted in: General

Medication Safety Review HKEH QA Forum 2012. Presented by David CHOI Resident Pharmacist, HKEH 22/March 2012. MI Reported to Drug Monitoring Committee in 2011. Entry of Complicated Regimen.

Download Presentation

Medication Safety Review HKEH QA Forum 2012

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Medication Safety Review HKEH QA Forum 2012

Presented by David CHOI

Resident Pharmacist, HKEH

22/March 2012


MI Reported to Drug Monitoring Committee in 2011


Entry of Complicated Regimen

The system allows entry of 5 different regimen types. Doctors no longer need to enter the dosage instruction in the special instruction box for majority of the case.


Entry of Complicated Regimen

Example of tapering dose regimen


List of KCC Approved / Standard Drug Abbreviations in Prescribing

Approved and adopted by Medication Safety Committee KCC,(Last updated Aug 2010)( I )

  • HA approved abbreviations

  • "Vitamin" abbreviated to Vit e.g. Vit B12, Vit E

  • Chemical name acronym

  • Abbreviation well established in medical literature

  • Low risk of misinterpretation with other abbreviations / drug names

  • Common knowledge of abbreviation by all health care professionals within organisation (HA)


List of KCC Approved / Standard Drug Abbreviations in Prescribing

Approved and adopted by Medication Safety Committee KCC,(Last updated Aug 2010)( II )


List of KCC Approved / Standard Drug Abbreviations in Prescribing

Approved and adopted by Medication Safety Committee KCC,(Last updated Aug 2010)( III )


List of KCC Approved / Standard Drug Abbreviations in Prescribing

Approved and adopted by Medication Safety Committee KCC,(Last updated Aug 2010)( IV )


List of KCC Approved / Standard Drug Abbreviations in Prescribing

Approved and adopted by Medication Safety Committee KCC,(Last updated Aug 2010)( V )


List of KCC Approved / Standard Drug Abbreviations in Prescribing

Approved and adopted by Medication Safety Committee KCC,(Last updated Aug 2010)( VI )


List of KCC Approved / Standard Drug Abbreviations in Prescribing

Approved and adopted by Medication Safety Committee KCC,(Last updated Aug 2010)( VII )


Common Abbreviations being used in HKEH

Dexamethasone 0.1% + Chloramphenicol 0.5% 5ml

Optomycin-D Decadron-C DC 

Dexamethasone 0.1% + Neomycin 0.5% 10ml

Dexoptic-N Decadron-N DN 

Mydrin-P Eye Drops 10ml

Mydrin-PMP


G6PD Deficiency Contraindication Checking

The local G6PD deficiency contraindicated drug lists used at HA hospitals were found to be quite inconsistent as users consult different reference sources when they prepare the list. The computerized G6PD deficiency contraindication checking is sourced from clinical data provided by First Data Bank, Inc. (FDB). You might notice discrepancies between FDB’s G6PD deficiency contraindicated drug list and the one prepared by local hospital. Through rounds of discussion, doctors in Medication Order and Decision Support Working Group (MODSWG), CPO and FDB representatives collaborated to review and fine-tune FDB’s list to be used for this G6PD deficiency contraindication checking.

All quinolones except Nalidixic Acid are not included in the FDB’s G6PD deficiency contraindicated drug list because FDB has contacted Dr. Ernest Beutler, MD of Scripps Research Institute and leading expert on G6PD deficiencyand Dr. Beutler replied that he was not aware of any documented case reports of quinolones causing hemolysis in G6PD deficient individuals.


  • Case

  • Allergen: Amiodarone HCL

  • Pregnancy Contraindication Checking: ON

  • Current Rx:

  • Amiodarone HCL Tablet

  • Sotalol HCL Tablet

  • On Hand Drug:

  • Propafenone HCL Tablet


Case (with on hand drug Propafenone)


Case (with on hand drug Propafenone)


Perform patient-specific clinical checking (including drug allergy checking, G6PD deficiency and pregnancy contraindicated checking) upon clicking “Edit” or “Add” button on the drug search screen

Case (with on hand drug Propafenone)


Case (with on hand drug Propafenone)


Case (with on hand drug Propafenone)


Case (with on hand drug Propafenone)


Case (with on hand drug Propafenone)


Perform drug-drug interaction checking upon clicking “Save and Print” button

Case (with on hand drug Propafenone)


Check Amiodarone against other drug(s) on the current Rx.

Case (with on hand drug Propafenone)


Check Amiodarone against local on-hand drug

Case (with on hand drug Propafenone)


Case (with on hand drug Propafenone)


Case (with on hand drug Propafenone)


HA list of High Risk Medications


LASA (Look-Alike Sound-Alike) Medications (I)


LASA (Look-Alike Sound-Alike) Medications (II)


LASA (Look-Alike Sound-Alike) Medications (III)


LASA (Look-Alike Sound-Alike) Medications (IV)


LASA (Look-Alike Sound-Alike) Medications (V)

QEH LASA Drug List :

DuoTRAV / DuraTEARS

TRAMadol / PANAdol

XalaCOM / XalaTAN

HKE LASA Drug List :

XalaCOM / XalaTAN

1% Pilocarpine / 2% Pilocarpine / 4% Pilocarpine

Maxitrol Oc. / Maxidex Oc.


Acknowledgement

Presentation materials

Prepared by

Mr Ng Chi Ming

HKE DM(Pharm)


Thank You


  • Login